Melanoma 2020: 30th Annual Cutaneous Malignancy Update
C

H&N Surgeon’s Perspective on Melanoma Management: Close Surveillance or CLND Are Equivalent for +SLND Biopsy Pts

By Melanoma 2020: 30th Annual Cutaneous Malignancy Update FEATURING Christopher Bergeron
By Melanoma 2020: 30th Annual Cutaneous Malignancy Update FEATURING Christopher Bergeron
6 views
March 6, 2020
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
23:16
Melanoma 2023: 33rd Annual Cutaneous Malignancy Update

2023 Updates on Dysplastic Nevi

Feat. B. Kelley
09:00
AAD 2024 Insights

AAD 2024 Insights: What's New In Nail Tumors

Feat. J. Dominguez-Cherit
23:09
Total Health

Key Updates in Skin Melanoma

Feat. R. Seedor
08:48
David Polsky

Promoting Skin Self-Exam for the Secondary Prevention of Melanoma

17:39
Melanoma Bridge 2023

Major Emerging Paradigm Shifts That Will Change Melanoma Management …

Feat. A. Eggermont
05:20
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Impact of Immune Checkpoint Inhibition on…

Feat. E. Buchbinder
19:52
OncoAlert

Melanoma Updates: Adjuvant Therapy, Advanced Disease, Uveal Melanoma…

Feat. A. Betof Warner
21:04
Penn Medicine Abramson Cancer Center

Pediatric Melanoma

Feat. M. Jen
21:12
Robert Swerlick

Dealing With Melanoma Overdiagnosis: Can We Find an Off-Ramp?

08:46
Sapna Patel

Neoadjuvant Immunotherapy in the Treatment of Melanoma: What Do We K…

13:12
2023 Year in Review

Year in Review: Surgical Treatment of Acral Melanoma

Feat. M. Leventer
14:00
Melanoma Bridge 2023

Is SLN Biopsy No Longer Necessary for Patients With High-Risk Primar…

Feat. J. Luke
04:45
Sapna Patel

Optimal Duration of Neoadjuvant Treatment in Melanoma: What We Do No…

17:38
Melanoma 2024: 34th Annual Cutaneous Malignancy Update

Beyond the Primary: Comprehensive Evaluation of the Melanoma Patient…

Feat. F. Fish
25:10
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

Immunotherapy Combinations in Melanoma in 2024

Feat. J. Moyers
11:56
Melanoma Bridge 2023

Adjuvant Therapy in Stage II Melanoma: Tools to Balance the Choice

Feat. P. Ascierto
16:00
AACR 2023 Conference Coverage

A Personalized Cancer Vaccine mRNA-4157 + Pembro vs. Pembro in Resec…

Feat. J. Weber
29:40
Melanoma 2023: 33rd Annual Cutaneous Malignancy Update

Melanoma, the Primary Lesion: Biopsy, Excision, and Mohs Surgery in …

Feat. D. Kent
24:22
Total Health

2022 Sedona Melanoma Updates From ASCO: Overview and Treatment

Feat. K. Lewis
21:38
Penn Medicine Abramson Cancer Center

Updates in Systemic Therapy for Melanoma

Feat. T. Mitchell